Viewing Study NCT06908434


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-27 @ 11:36 PM
Study NCT ID: NCT06908434
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-03
First Post: 2025-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module